Macter International Limited (PSX:MACTER)
Pakistan · Delayed Price · Currency is PKR 358.10
-6.72 (-1.84%)
At close: Oct 20, 2025
Macter International Revenue
In the fiscal year ending June 30, 2025, Macter International had annual revenue of 10.36B PKR with 29.91% growth. Macter International had revenue of 2.26B in the quarter ending September 30, 2024, with 57.85% growth.
Revenue
10.36B
Revenue Growth
+95.18%
P/S Ratio
1.58
Revenue / Employee
8.08M
Employees
1,282
Market Cap
16.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 10.36B | 2.39B | 29.91% |
| Jun 30, 2024 | 7.97B | 1.05B | 15.14% |
| Jun 30, 2023 | 6.93B | 1.55B | 28.91% |
| Jun 30, 2021 | 5.37B | -331.94M | -5.82% |
| Jun 30, 2020 | 5.70B | 1.51B | 35.99% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 72.39B |
| GlaxoSmithKline Pakistan | 62.62B |
| The Searle Company | 28.60B |
| Shifa International Hospitals | 27.97B |
| AGP Limited | 26.11B |
| Highnoon Laboratories | 25.78B |
| Ferozsons Laboratories | 18.86B |
| Citi Pharma | 13.15B |